Patterns of Palliative Radiotherapy Utilization for Patients With Metastatic Breast Cancer in Harare, Zimbabwe

• Published in: JCO global oncology Vol. 7; no. 7; pp. 1212 - 1219
• Main Authors: Mushonga, Melinda, Nyakabau, Anna Mary, Ndlovu, Ntokozo, Iyer, Hari Subramaniam, Bellon, Jennifer Ruth, Kanda, Caroline, Ndarukwa-Jambwa, Sandra, Chipidza, Fallon, Makunike-Mutasa, Rudo, Muchuweti, David, Muguti, Edwin G., Cluff Elmore, Shekinah Nefreteri
• Format: Journal Article
• Language: English
• Published: Wolters Kluwer Health 01.12.2021; American Society of Clinical Oncology
• Subjects: ORIGINAL REPORTS
• ISSN: 2687-8941; 2687-8941
• DOI: 10.1200/GO.20.00656

PURPOSE In sub-Saharan Africa, radiotherapy (RT) utilization and delivery patterns have not been extensively studied in patients with metastatic breast cancer. METHODS A retrospective cohort study of female patients with metastatic breast cancer seen at Parirenyatwa Radiotherapy Centre in Zimbabwe from 2014 to 2018 was conducted. Demographics, pathology, staging, and treatment data were abstracted through chart review. Fisher's exact test and chi-squared test of independence were used to compare proportions, and independent two-sample t-tests were used to compare means. RESULTS Of 351 patients with breast cancer, 152 (43%) had metastatic disease, median age 51 years (interquartile range: 43-61 years). Of those with metastatic disease, 30 patients (20%) received radiation to various metastatic sites: 16 spine; three nonspine bone metastases; six whole brain; and five chest wall or supraclavicular. Patients who received radiation were younger (46 v 52 years; P = .019), but did not differ significantly by performance status than those who did not. The most common dose prescription was 30 Gy in 10 fractions (33%). Five (17%) patients had treatment interruption and two (7%) had treatment noncompletion. Province of origin and clinical tumor stage were significant predictors of RT receipt ( P = .002; and P = .018, respectively). CONCLUSION A minority of patients with metastatic breast cancer received RT (20%), and these were likely to be younger, with advanced tumor stage, and resided in provinces where RT is available. Conventional courses were generally prescribed. There is a need to strongly consider palliative RT as an option for patients with metastatic breast cancer and use of hypofractionated courses (e.g. 8 Gy in one fraction) may support this goal.